
Gimv
Description
Gimv is a prominent European private equity and venture capital firm with a rich history spanning over four decades, having been established in 1980. Listed on Euronext Brussels, the firm has cultivated a reputation as a long-term, active investor focused on fostering growth in established companies across various sectors. With approximately €1.6 billion in assets under management as of September 30, 2023, Gimv invests both from its own balance sheet and through third-party funds, demonstrating a robust and flexible capital base. Its strategic approach emphasizes building strong partnerships with management teams to drive sustainable value creation.
The firm's investment strategy is structured around four distinct platforms: Connected Consumer, which targets consumer goods, retail, and digital consumer services; Health & Care, focusing on medtech, digital health, and care services; Smart Industries, encompassing advanced manufacturing, industrial services, and cleantech; and Sustainable Cities, which includes infrastructure, real estate, and energy transition initiatives. This platform-based approach allows Gimv to leverage deep sector expertise and a broad network to identify and support high-potential companies. They typically seek out growth-oriented businesses with enterprise values ranging from €20 million to €500 million, indicating a focus on the lower-mid to mid-market segments.
Gimv primarily targets companies located in the Benelux region, France, and Germany, while also increasingly exploring opportunities across the broader European landscape. The firm's typical equity investment per transaction ranges from €10 million to €50 million, providing significant growth capital for expansion, internationalization, and strategic acquisitions. Their commitment extends beyond mere capital provision, offering strategic guidance and operational support to help portfolio companies achieve their full potential. This comprehensive approach underscores Gimv's dedication to being a true partner in growth, contributing to the long-term success of the businesses they back.
Investor Profile
Gimv has backed more than 189 startups, with 3 new investments in the last 12 months alone. The firm has led 61 rounds, about 32% of its total and boasts 60 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, Belgium, France.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $10.8M – $54M.
Stage Focus
- Series B (23%)
- Series Unknown (21%)
- Series A (16%)
- Series C (15%)
- Private Equity (14%)
- Series D (6%)
- Series E (2%)
- Series F (1%)
- Seed (1%)
- Post Ipo Equity (1%)
Country Focus
- United States (24%)
- Belgium (23%)
- France (15%)
- The Netherlands (13%)
- United Kingdom (7%)
- Germany (6%)
- Switzerland (5%)
- Ireland (2%)
- Israel (1%)
- Canada (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Software
- Therapeutics
- Manufacturing
- Medical Device
- Pharmaceutical
- Biopharma
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.